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Abstract
There is a need for formalised diagrams that both summarise current biological pathway
knowledge and support modelling approaches that explain and predict their behaviour.
Here, we present a new, freely available modelling framework that includes a biologist-
friendly pathway modelling language (mEPN), a simple but sophisticated method to support
model parameterisation using available biological information; a stochastic flow algorithm
that simulates the dynamics of pathway activity; and a 3-D visualisation engine that aids
understanding of the complexities of a system’s dynamics. We present example pathway
models that illustrate of the power of approach to depict a diverse range of systems.
This Community Page is part of the Cool Tools Series.
How to Draw Diagrams of Biological Pathways?
Biologists the world over love a good diagram. The old adage of a picture being worth a thou-
sand words holds true. Diagrams continue to form the bedrock of our efforts to communicate
ideas about the complexity of biological systems and pathways. They act as pictorial reviews of
what is known about the components of a given system and how they interact. However, there
is a fundamental problem with most biological pathway diagrams: they are produced on an ad
hoc basis with no rules governing their composition or content. As a result, they convey infor-
mation only in the narrow context of the accompanying legend, text, or talk, and as a collective
resource are of limited use as they cannot be directly compared or integrated.
If pathway modelling is to be more widely adopted by biologists and the results of their
efforts useable by others, a new approach is required. Here, we describe a modelling framework
that consists of a formalised graphical language that supports the depiction of complex
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biological interactions and molecules, allowing the creation of detailed models of events based
on known information. Once parameterised, these models can then be used directly for experi-
ments that seek to simulate their activity under a variety of conditions. The approach utilises
flexible and simple-to-use tools that make diagrams easy to draw and edit as new knowledge
arises, and to model their behaviour. Most importantly, the resulting pathway diagrams are
useful in the communication of ideas, in hypothesis testing, in enhancing the understanding of
the dynamic characteristics of the system modelled, and thereby in helping to drive forward
biological research objectives.
The post-genomic era has led to the generation of a massive amount of data on the interac-
tions between molecules across cell types and disease processes. Pathguide.org [1] lists and cat-
egorises many of the available resources providing access to this information; it currently lists
547 websites and databases (as of May 2016). Many are databases of collated biological interac-
tion data, experimentally determined or inferred; some well-known examples include String
[2], GeneMania [3], ConsensusPathDB [4], IntAct [5] and BioGrid [6]. Other initiatives have
sought to ensure there are common standards to exchange this information such as Pathway
Commons [7] and PSICQUIC [8]. However, these resources store and serve up interaction
data primarily as pairwise interactions, in which the context, nature, or result of these interac-
tions are generally not shown. In other words, the data exist as a simple network of interac-
tions, not as a formalised pathway diagram. Representing the interactions between biological
components as pathways is a challenge, and a number of notation schemes have been proposed
[9–15], culminating in the establishment of the Systems Biology Graphical Notation (SBGN)
project. In 2009, the SBGN community proposed a number of standards for pathway depiction
including the “process description language” [12] based on ideas first proposed by Kitano et al.
[9]. In process description diagrams, components of a pathway are depicted using a standard
set of shapes (glyphs), and both the nature of the interactions between components and the
products of those interactions must be shown explicitly. Since its original description, a num-
ber of individual models have been constructed based on this approach [16–22], and a number
of databases [23–26] now provide centralised pathway resources constructed using a SBGN-
like process description notation. Other popular pathway diagram databases such as KEGG
[27] and WikiPathways [28]use their own notation systems. Whilst adoption of SBGN’s pro-
cess description language by parts of the community undoubtedly represents a step in the right
direction, many aspects of the SBGN scheme are limiting; the depiction of many common con-
cepts in biology are not supported and the computer-science–based language used to describe
it can be alienating to biologists. Finally, tools that support SBGN pathway construction are
not always easy to use or have limited functionality and, at present, models cannot be used
directly for activity simulation experiments.
A Biologist-Friendly Approach to Pathway Modelling
A number of years ago, we started to explore the problem of how does one draw a “good” dia-
gram of a biological pathway. In order to ensure the usability and widest appeal of our
approach, we have strived to ensure that the diagrams (graphical models) produced were able
to depict events as described in the literature in as much detail as possible whilst maintaining
their readability. We also wanted the approach to be understood and useable by relatively
junior biologists, as in many cases they were the ones constructing models. To these ends, we
developed the modified Edinburgh Pathway Notation (mEPN) scheme (for an up-to-date ver-
sion, see Fig 1). In common with SBGN, the mEPN scheme is also based on the principles of
the process diagram (see Box 1 for a comparison of the mEPN scheme to SBGN). The mEPN
scheme is designed to be clear and concise, and to embrace the use of colour to enhance the
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readability of diagrams. The excellent yEd (www.yWorks.com) software is the primary path-
way drawing tool, providing a platform that is robust, flexible, and free to use. It has a range of
features that allows a user to link parts of the model to external resources or other supporting
data (e.g., PDF files of informative papers and websites) and provides an easy-to-use platform
for diagram visualisation and editing. An extended description of construction of mEPN mod-
els is provided in S1 Text, and a protocols paper in which we have sought to provide a detailed
guide to any would-be pathway modeller is available on bioRxiv preprint server (http://dx.doi.
org/10.1101/047043).
Fig 1. The modified Edinburgh Pathway Notation (mEPN) scheme, version 2.0.Nodes are classed as being either a “place” or
“transition” and are connected by “edges.” The scheme consists of 12 different entity nodes (top left panel) representing different kinds of
molecular species. Also included are a Boolean logic “OR” operator node and a spacer node that may be required to maintain bipartite
structure. Entity nodes are annotated to describe the identity and state of the entity, e.g., protein symbol and its modifications (bottom left
panel). Also included in the scheme are 45 different process nodes (top central panel), the majority representing different interactions that
can take place between place pathway entity nodes. Also included in this class of nodes are a Boolean logic “AND” operator node, a sink
node, two token input nodes, and a spacer node. There are six possible connecting edges (bottom central panel) that represent the nature
of the interaction between a place and a transition, two of which are inhibitor edges and one of which is a non-directional edge that
represents a non-covalent interaction. Components are represented in the context of their subcellular location, represented by “container”
nodes of specific colours (right panel). In all cases, colour is not essential to defining node type but is designed to aid visual distinction
between them.
doi:10.1371/journal.pbio.1002530.g001
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Box 1. mEPN Versus SBGN
SBGN is perhaps the most widely employed graphical notation scheme in use today for
pathway modelling. The objectives of SBGN are aligned with our own, and the mEPN
scheme has borrowed concepts from it. Indeed, models constructed using the mEPN
scheme may be exported from within BioLayout Express3D as a SBGN-ML file, from
whence they may be viewed and edited within tools that support SBGN, e.g., Vanted (Fig
2) [29]. In our experience, however, the SBGN scheme is overly complicated for an audi-
ence of biologists and is limiting in terms of its ability to depict certain processes; we
believe the mEPN scheme offers certain advantages. However, where possible, we have
attempted to maintain consistency with the SBGN standard, but there are a number of
areas where we have chosen to deviate from it.
1. SBGN uses a number of non-geometric shapes to depict a number of pathway entity
types (or EntityPoolNodes, as they are referred to in SBGN). These shapes are not
supported by yEd or, indeed, other generic network editors and are not used in the
mEPN scheme.
2. Protein complexes are represented in SBGN using either a “stack of proteins” glyph in
the case of homo-multimers or as a series of individual protein subunit glyphs within
container node in the SBGN scheme. In mEPN, all such entities are represented as a
single rounded rectangle glyph in which the number and name of constituent entity
nodes are defined by the node’s label; we see no advantage graphically or otherwise in
rendering complexes by the means proposed by SBGN. In drawing larger complexes,
we have also often found it useful to show individual proteins/subunits as individual
entities joined by edges with no arrows (the so-called “non-covalent interaction” edge)
so that the structure and relative position of individual subunits might be better com-
municated graphically (see Fig 3B, a model of the nuclear pore). However, such mod-
els cannot currently be used in the computation modelling environment as they do
not conform to requirements for a bipartite graph structure of computational models.
3. SBGN has specific glyphs for association (binding) and dissociation, but almost all
other processes are represented by a square box. This gives no information on the pro-
cess they represent and is an important omission. In mEPN, we currently list 40 types
of processes that one might wish to define when constructing a pathway, including all
of those associated with the BioPAX level 3 pathway exchange language [30]. Whilst in
the computational modelling environment of the signalling Petri Net (SPN), all transi-
tion nodes function the same; it is important to differentiate between what are often
quite different processes in order to aid understanding and readability of the models.
We have added the black rectangle and diamond transitions for modelling purposes.
4. We have simplified the list of edges representing interactions between entity nodes
down to interaction, catalysis, inhibition, and the special use case action potential,
and do not recognise many of the options available listed by SBGN (i.e., consumption,
production, reversible modulation, necessary stimulation, logic, and equivalence
arcs), as we have found them difficult to explain to biologists and not necessary to the
depiction of pathways.
5. Finally, perhaps the most important issue for computational modelling purposes is
that in the current version of mEPN, we define all nodes as being either places or tran-
sitions, a division that makes biological sense in terms of what they represent and con-
forms to the requirement of Petri net models.
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An example of a simple model of the signalling pathway of Interferon-β (IFNB1) rep-
resented in the mEPN scheme, BioLayout Express3D, and SBGN diagram or a Petri net
can is shown in Fig 2 for comparison.
Fig 2. A simple pathway represented in four different ways. This figure represents a simplified model of the
interferon-β signaling pathway. (A) Shows this pathway represented using the mEPN scheme and parameterised
ready to run a simulation, (B) when imported into BioLayout Express3D and visualised using themEPN 3D
notation scheme, (C) as exported fromBioLayout as an SBGN-ML file and loaded in the Vanted software, and
(D) the same set of interactions represented as a Petri net, illustrating the similarity to mEPN diagrams.
doi:10.1371/journal.pbio.1002530.g002
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At its most basic level, a pathway diagram constructed using the mEPN scheme is a simple
network composed of nodes and edges. Nodes fall into one of two categories representing
either pathway entities or processes. Entity nodes generally represent biomolecules (e.g., RNAs,
proteins, complexes, biochemicals), and each class of entity is represented by a glyph of a par-
ticular shape. Process nodes represent an event occurring to or between entities (e.g., transloca-
tion, binding, dissociation, phosphorylation), and are generally represented by a circle with a
two- to three-letter label distinguishing between the different types of processes they represent.
The lines that join nodes, called edges, define the direction of an interaction and in some cases
Fig 3. Examples of pathways and complexes represented usingmEPN. (A) A model of the human TCA cycle and glycolysis pathways
drawn using the mEPN scheme. The insert shows a small section of the pathway demonstrating the different shapes and colours used to
depict different classes of molecule and how different types of processes can be distinguished using differently labelled process nodes.
This is a purely graphical model, but with parameterisation it could be used to run simulations of this pathway. (B) Depiction of the nuclear
pore complex as an example of how the mEPN scheme can be used to represent large structures composed of multiple subunits. In all
models constructed by us, standard nomenclature is used to define entities (e.g., Human Genome Nomenclature Committee [HGNC]-
approved names for human proteins and genes) to remove ambiguity of what is being represented.
doi:10.1371/journal.pbio.1002530.g003
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the nature of it (e.g., catalysis, action potential, inhibition, or non-covalent interaction). A
model of the well-known pathways of the glycolysis and the tricarboxylic acid (TCA) cycle con-
structed using mEPN is shown in Fig 3A, and an example of how a large complex such in the
nuclear pore can be shown to be made up of multiple connected subunits using the non-cova-
lent edge is shown in Fig 3B (these models are also available to download and edit in S1
GraphML).
Beyond the Picture
A hallmark of many modern biological investigations are genome-scale analyses, which con-
tinue to produce huge amounts of data. These inevitably implicate hundreds or thousands of
biological entities as being of interest due to their change in abundance in a given experimental
or clinical paradigm. However, interpretation of the meaning of such observations represents
one of the greatest challenges in biology today. Gene Ontology (GO) enrichment analyses may
indicate that a set of gene or protein “hits” are implicated in a given pathway or process, but
what role they play or how they function together is not defined. Similarly, and as mentioned
above, protein–protein interaction databases may be used to find out if there is any evidence
that a set of proteins share a functional association, but the information returned is generally
without context. An alternative approach is to overlay results onto pathway diagrams, thereby
indicating which of those represented have been regulated. The researcher can then understand
not only which pathways have undergone regulation but which specific elements have been
altered, allowing them to hypothesise how a given perturbation might affect a pathway’s activ-
ity or downstream events. This method is very useful but limited by the quality and scope of
the reference pathway diagram. There are a number of tools that currently support data visuali-
sation in the context of networks and pathways, including CellDesigner [31], NaviCell [25],
KEGGMapper [27], ReactomeFiViz [32], iPath [33], and Medusa [34]. As knowledge of bio-
logical interactions grows, there is, therefore, a need to construct better models to support
these types of analysis, and we present here our approach to constructing such models.
This brings us to perhaps the most challenging aspect of pathway modelling: that of simulat-
ing their activity. To truly comprehend a pathway, one needs not only the pictorial representa-
tion or “connectivity map” but also to understand the dynamics of the system under different
conditions. Computational and mathematical modelling studies aim to simulate biological sys-
tems to explain a pathway’s observed activity. When this is achieved, models can be used to
explain or predict a system’s response to perturbations (e.g., a drug treatment, gene knockout,
etc.) or to predict missing components. Over the years, numerous computational models have
been published for a diverse assortment of biological systems (see the BioModels database for
examples [35]). Researchers have used a range of approaches to simulate system dynamics,
including ordinary and partial differential equations, qualitative differential equations, stochas-
tic equations, directed graphs, Bayesian and Boolean networks, and rule-based formalisms
[36,37], and the Systems Biology Markup Language (SBML) has been developed as an open
interchange format for such models. Most equation-based models are described primarily by
the maths, and graphical representation of the events being modelled is generally an after-
thought. Indeed, whilst mathematical modelling of biological pathways was one of the found-
ing activities of systems biology, currently, pathway depiction and pathway modelling are
generally considered to be separate disciplines. The aim of one is draw an accurate representa-
tion of known events, the other to understand how a pathway might operate as a dynamic sys-
tem; the two activities are generally not compatible. However, it is the requirement for
experimentally derived rate constants to feed into many of these models, and the significant
computational power required to solve a series of equations generally limits equation-based
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approaches to modelling relatively small and well-characterised systems [38]. These factors
have limited the routine use of modelling by biologists who are generally not comfortable with
the mathematical modelling techniques employed.
Modelling Pathway Dynamics Using Activity Flow Simulations
Process diagrams share much in common with Petri nets, a modelling approach that has been
used to model many different types of systems, with a growing literature describing their use in
modelling biological pathways [39–41]. Petri nets are a rule-based approach founded on the
concept of modelling the flow of tokens through a system in which tokens represent the activity
(or amount) of a given component. Petri nets are networks made up of two types of node:
places and transitions (usually represented by circles or black rectangles, respectively). A strict
requirement of Petri nets is that they are constructed as bipartite graphs, i.e., they have a recur-
rent structure of place–transition–place (or in the case of process diagrams, entity–process–
entity). The signalling Petri Net (SPN) algorithm we have employed to dynamically model flow
through mEPN diagrams was originally described by Ruths et al. [38], which, after refinement,
was incorporated into the network visualisation and analysis software BioLayout Express3D
(www.biolayout.org). As part of this development, we enabled the import and visualisation of
mEPN models and thereby the simulation of activity flow through such models. In order to
achieve this end, we modified the mEPN scheme to define all nodes as representing either
places (which includes all pathway entities) or transitions (which includes all nodes represent-
ing processes). An extended description of the SPN modelling system is provided in S1 Text
and in the accompanying protocol paper (http://dx.doi.org/10.1101/047043).
Models need to be parameterised prior to running a simulation, i.e., the initial conditions for
the experiment need to be set. With this modelling platform, parameterisation is, in principle,
relatively simple to perform and is based on information that may be available to a biologist.
The primary parameterisation is the structure of a model itself; this is the major determinant of
where tokens can flow to and from, and how long it takes for them to move from place to
another. Parameterisation is also carried out through the placement of tokens on entities at the
starting points of a network, i.e., on places that have no parents. An entity without tokens, or
where token number is set to zero, can be considered not to exist (e.g., a knockout or not
expressed). The more tokens placed on an entity node prior to running the model, the more of
that entity (or the greater its activity) at the beginning of a simulation. The assignment of tokens
to an entity node can be arbitrary or inferred from experimental evidence, such as gene expres-
sion or proteomics data, where available.
Models constructed using the mEPN scheme, parameterised and then saved in yEd as
GraphML files, can be loaded into the tool BioLayout Express3D. BioLayout has been designed
to recognise the different glyphs used in the mEPN scheme and translates all 2-D mEPN glyphs
into their 3-D equivalents, e.g., circles become spheres, rounded rectangles become rounded
cuboids (Fig 3A and 3B). The 3-D palette of shapes being far larger allows greater flexibility to
distinguish between certain entity types. BioLayout can also export a SBGN-ML version of a
mEPN model such that it can be loaded into an SGBN-compliant platform such as SBGN-ED
[42] as used here (Fig 2C). Shown in Fig 2D is an illustration of how the concepts of the mEPN
language map onto the bipartite graph structure of a Petri net.
When an mEPN model is loaded, BioLayout requests whether a simulation is required.
On answering yes, a dialogue is presented (S1 Fig) by which conditions for the SPN simula-
tion can be set, i.e., mode of stochasticity, number of runs and time blocks, etc. A simulation
is made up of a series of “time blocks” in which each transition in the model is “fired” exactly
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once in a random order and tokens are moved from the place(s) upstream of the transition to
the downstream place(s). In the default mode, the number of tokens moved is essentially ran-
dom, i.e., between zero and the maximum number of tokens available. A series of time blocks
is referred to as a “run,” and a simulation may involve one or many runs, each run beginning
at the same initial token marking. The result of a simulation for a given pathway entity node
(place) is the average accumulation of tokens across individual runs and, as such, is associ-
ated with a measure of variance. The more runs performed, the more reproducible results
will be across separate simulations. It should be noted that even when running simulations
on large models over many time blocks composed of hundreds of runs, computational times
for the SPN algorithm are normally no more than a few seconds (S1 Fig). Following a simula-
tion run, the activity of the system and individual entities within it is represented by the flow
of tokens from one entity node to another over time. One way to view results is through the
animation of this token flow, a node’s size and colour being used to represent token accumu-
lation over time. This is a capability enabled within BioLayout, which has an interface that
allows the user to control many aspects of this animation (S1 Fig). This functionality provides
a powerful visual medium to appreciate token flow in large network diagrams and can be
used to troubleshoot the innate challenges associated with model construction. Indeed, the
general modus operandi when optimising models is to construct them in yED, test the flow
characteristics in BioLayout, and solve issues encountered by going back to the model in yED
and then retesting the model. In reality, the movement between the two tools is quick, and
model testing and improvement can be a rapid process. See S1 Video for a summary of the
modelling process.
Flow Characteristics through Basic Pathway Motifs
Linear Flow
In a linear network consisting of a line of alternating places and transitions, each time a transi-
tion is fired, tokens will “flow” down the network; the more tokens added, the more tokens will
accumulate downstream (Fig 4A.i). With a constant input of tokens, token accumulation rises
to a constant level and remains “steady,” the rate of tokens entering a place approximating
those leaving; places close to the start of the line accumulate tokens faster than those further
downstream (Fig 4A.ii). When tokens are added in for a fixed number of time blocks (i.e., a
pulsed input), a wave of flow is produced, the amplitude of the wave reducing and its wave-
length increasing at places downstream of the input (Fig 4A.iii). Variation of flow over time
under steady state conditions depends on the number of runs performed and the randomness
of signal propagation (Fig 4B).
Flow through Interactions between Multiple Entities
Pathways are made up of a small number of basic network motifs [43]. When transitions
receive numerous inputs, they function as rule-based regulators of token flow. A basic rule is
that when the number of tokens on input places is not equal, the number of tokens taken for-
ward will be based on the input place with the least number of tokens (Fig 4C, red). In the case
of multiple inputs into places, inputs are additive (Fig 4C, green). In instances where there are
multiple outputs from a transition, the number of tokens on the upstream place will be mir-
rored by downstream places, i.e., flow is preserved (Fig 4D, yellow). Where outputs come direct
from a place, the number of tokens on the upstream place will divided randomly amongst
downstream places, i.e., flow is divided (Fig 4D, purple).
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Fig 4. Flow simulation through simple pathwaymotifs. (A) A linear network with tokens added to the system on the first
node (X) illustrates how differences in the placement of tokens and SPN parameters affect token output flow. Token
accumulation on the blue, red, and green nodes in the network has been used to illustrate the effect changing the number
and/or pattern of tokens introduced. (i) Varying the initial token input (X = 50, 100, or 200), (ii) the rate of token accumulation
at different points downstream of a constant input (X = 100), and (iii) token flow following a pulsed input of tokens (100
tokens during time blocks 11–30). (B) Token accumulation on the blue node illustrates the effect on changing the number of
runs and stochasticity of the SPN algorithm (X = 100). (C) Modelling multiple inputs into a place. The red node shows two
places feeding into a downstream place via a transition node where flow is determined by the upstream node with the least
number of tokens. Input to the green node is via separate transitions; token accumulation is additive. (D) Modelling multiple
outputs from a place. In the first instance, where output from the blue node is via a single transition, the yellow downstream
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Feedback Control
Feedback loops are a fundamental feature of biological systems, and an ability to model them is
an essential property of any modelling system. Inhibitor edges have a unique function. They
originate from an entity (the inhibitor) and connect with a transition node, i.e., the process that
is to be inhibited. This system includes two types of inhibitor edge representing non-competi-
tive and competitive inhibition. The first operates on the basis that if any tokens are present on
the inhibitor, flow through the transition is completely blocked. In the second case, the number
of tokens residing on the inhibitor is subtracted from the number of tokens flowing through
the transition. As no tokens are lost through inhibitor edges, it has become standard practice to
draw inhibitor places with an associated output transition (sink). Without this, flow through a
negative feedback loop is completely and irrevocably stopped as tokens accumulated on the
inhibitor remain there, blocking further flow through the target transition. An inhibitor with a
sink transition node attached effectively has a half-life (as tokens are lost from the inhibitor via
the sink) and, depending on the configuration of the feedback loop, e.g., path length between
input and inhibitor and type of inhibition (amongst other factors), the system may exhibit a
range of oscillatory activities (Fig 4E).
Described above are the characteristics of flow simulations through basic pathway motifs. It
should be noted that this method is scalable, and large pathway models consisting of hundreds
or possibly thousands of nodes can be constructed and used in flow simulation experiments.
We present a recently constructed model of the influenza life cycle in macrophages as an exam-
ple of such a large-scale model (Fig 5). See also S2 Text, S2 Graphml, S2 Fig and S3 GraphML
for a description of this pathway and for access to the model itself.
The Challenges and Rewards of Pathway Modelling: A Biologist’s
Perspective
Described above are the basic characteristics of the flow simulation algorithm and how this
approach maps onto pathway diagrams assembled using the mEPN scheme. This interopera-
bility between an advanced graphical notation scheme and a powerful and rapid dynamic
modelling platform opens up pathway modelling to a wider audience. However, modelling a
pathway of any size is not a trivial undertaking—it takes skill, knowledge, and dedication.
From a biologist’s perspective, we would argue that the time and effort required to engage in
this activity is rewarded. For most researchers, a current pathway diagram describing their sys-
tem of interest will not exist, and constructing it themselves can be an extremely useful exercise.
It provides an opportunity for a biologist to formalise what they know in a form that can be
communicated to their peers or coworkers. It also provides a platform where additional infor-
mation can be added by others, thereby offering a medium for debate and a route to establish-
ing a common understanding. Indeed, one of the most valuable aspects of pathway modelling
node receives the same number of tokens as was present on blue, i.e., flow is conserved. When outputs are split from the
node itself, token output is distributed equally amongst downstream nodes (purple). (E) Negative feedback loops. In the
first case, a non-competitive inhibitor edge (i., red edge with a flat bar) will completely stop token flow through the target
transition if any tokens are present on the inhibitor node. By contrast, competitive feedback edge (ii., red edge with an open
diamond end), the number of tokens on the inhibitor node are subtracted from the number of tokens flowing through the
target transition. An additional factor in determining flow through a negative feedback loop is the number of steps between
input and feedback. The more nodes present between feedback receiver and inducer, the more tokens accumulate in the
system, resulting in a longer wavelength of the feedback and a greater amplitude of token flow, as illustrated here by the
differences between 1, 10, and 50 nodes between signal input and inhibitor. All token flow plots are shown as mean (darker
line) with standard error (lighter area around line).
doi:10.1371/journal.pbio.1002530.g004
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is the process of model construction itself and the opportunity it provides to systematically col-
lect and discuss available knowledge. By performing this act, it exposes what is not known or,
as is sometimes the case, why events as described could not possibly work the way they are
reported to. In a teaching environment, students can be engaged in the activity. They gain valu-
able experience in learning to mine the literature. They have to learn to be critical of the reli-
ability of information and to judge how to represent information when it is incomplete or
conflicting. How they go about this task and what they produce in terms of a “finished” dia-
gram can be judged and marked in the same way as any written assignment.
Fig 5. A model of the influenza A life cycle. (A) Representation of a large model of the life cycle of the
influenza A virus (IAV) and interactions with the host defence systems in a macrophage. The boxes highlight
the modular structure of the model. Modules of the viral replication pathway are indicated with black boxes;
modules of the macrophage host defence mechanisms are indicated with pink boxes. Model constructed and
visualised in yEd. (B) Visualisation of token flow through the IAV/macrophage model after SPN simulation in
BioLayout Express3D. (C) Approximately 14,000 tokens accumulate on the “virus output” node during SPN
simulation of the model when the host defence systems are removed (red) compared to approximately 4,000
for a naïve macrophage (purple) or <10 for an interferon primed macrophage (pink). (D) Pro-apoptotic
signalling reaches a peak of approximately 16,000 tokens in interferon-primed macrophages and 14,000 in
naïve macrophages, but pro-apoptotic pathways are little activated in the epithelial cell model (<800 tokens).
For more details on the assembly and parameterisation of this pathway and to download the pathway itself,
see S2 Text, S2 Graphml, S2 Fig and S3 GraphML.
doi:10.1371/journal.pbio.1002530.g005
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Summary
The modelling framework described here is flexible enough to model all the basic network
motifs found in all biological pathway types [43,44], allowing curators to represent and capture
pathway knowledge in great detail. It also supports the parameterisation of models according to
criteria that are readily accessible, i.e., the relative amount of specific entities can often be experi-
mentally determined or inferred, and tokens placed accordingly. Also, parameterisation of mod-
els such as introducing amplifications, reductions, or delays to signal propagation can be made
simply by marking such events on the models or by altering the structure of the model itself. We
present a number of worked examples of pathway models drawn using the mEPN scheme on
the Virtually Immune website (www.virtuallyimmune.org/) and BioLayout Express3D as a
means to model their dynamics. In these respects, we believe that the computational framework
presented here represents a major advancement in modelling biological pathways. We also
envisage that the tools and approaches described here will be useful to other groups: for
instance, those investigating single cell biology, where the response of individual cells in a popu-
lation is heterogeneous and stochastic [45] or synthetic biology, where the properties of an engi-
neered biological pathway module could be tested prior to construction. We also envisage that
the methodology will have application in the modelling of complex systems outside of biology.
Supporting Information
S1 Fig. Setting up BioLayout Express3D to run and visualise SPN simulations. (A) When an
SPN-ready model is loaded in BioLayout Express3D, the software automatically recognises it
and prompts users to run an SPN simulation using this window. The user defines the number
of time blocks and runs, whether the variance is displayed, the form of stochasticity with which
the model is parameterised, and the transition type. The set-up used for generating visualisa-
tions in this article is illustrated. (B) On completion of the SPN simulation run, this window
provides a time for the running of the simulation and prompts the user to repeat the simula-
tion, save the SPN results, or open the animation dialog. (C) The animation control dialogue
window allows the visualisation of the SPN simulation to be defined. Size and colour of nodes
as well as the appearance of token flow and the speed of the animation can be defined here.
(PDF)
S2 Fig. Construction and parameterisation of a representation of IAV life cycle in a cell
with no host defences. (A) Illustration of the modular structure of the IAV life cycle that facili-
tates its readability and allows for pathway expansion as new data become available or as a
focus of interest grows. (B) When our virtual cell is challenged by a limited amount of virus
(MOI 10 for two time blocks, ten virions are represented by ten input tokens, an accumulation
of the structural components haemagglutinin (HA), neuraminidase (NA), matrix protein 1
(M1), and nonstructural protein 2 (NS2) both at the (C) mRNA and (D) protein level leading
to (E) viral progeny (approximately 1E4 virions/cell Virus Output). The model outputs are
comparable to the levels of (F) mRNA and (G) protein accumulation seen in previously
reported experimental in vitro infection.
(PDF)
S1 GraphML. GraphML files of the models shown in Fig 2.
(GRAPHML)
S2 GraphML. GraphML file of the mEPN pathway representation of IAV life cycle in a cell
with no host defences.
(GRAPHML)
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S3 GraphML. GraphML file of the mEPN pathway representation of IAV life cycle in the
context of a macrophage (IFNB-primed).
(GRAPHML)
S1 Text. Methods and an extended description of the SPNmodelling system.
(DOCX)
S2 Text. Description of the assembly and parameterisation of a model of the IAV life cycle
in the context of a macrophage.
(DOCX)
S1 Video. Overview of the mEPN approach to pathway modelling and simulation.
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